Should You Buy Moderna Right Now?
Has (NASDAQ: MRNA) finally bottomed out? You may be asking that yourself right now, as shares in the biotech company have held steady at around $25 per share over the past six months.
Moderna might be a shell of its former self, no longer making billions from its COVID-19 vaccine, but it's still sitting on billions of dollars in capital. The company also has many promising candidates in its drug development pipeline.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€44.70
3.700%
With 7 Buy predictions and 8 Sell predictions the community is currently undecided on Moderna Inc..
The target price of 21 € compared with the current price of 44.7 € for the stock indicates a negative potential of -53.01%.
